TREVISAN, MATTEO
TREVISAN, MATTEO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting
2023 S. De Leo, M. Trevisan, C. Colombo, C. Moneta, N. Giancola, L. Fugazzola
Management of hypertension during Lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm
2023 C. Colombo, D. Ceruti, S. DE LEO, G. Bilo, M. Trevisan, N. Giancola, C. Moneta, G. Parati, L. Persani, L. Fugazzola
Daily Management of Patients on Multikinase Inhibitors' Treatment
2022 C. Colombo, S. De Leo, M. Trevisan, N. Giancola, A. Scaltrito, L. Fugazzola
Persistent Thyroid Carcinoma and Pregnancy: Outcomes in an Italian Series and Review of the Literature
2022 C. Colombo, S. De Leo, N. Giancola, M. Trevisan, D. Ceruti, F. Frattini, L. Persani, L. Fugazzola
SGLT2-inhibitors are effective and safe in the elderly: The SOLD study
2022 M.E. Lunati, V. Cimino, A. Gandolfi, M. Trevisan, L. Montefusco, I. Pastore, C. Pace, N. Betella, G. Favacchio, M. Bulgheroni, L. Bucciarelli, G. Massari, C. Mascardi, A. Girelli, P.S. Morpurgo, F. Folli, L. Luzi, M. Mirani, B. Pintaudi, F. Bertuzzi, C. Berra, P. Fiorina
Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism
2022 M. Trevisan, C. Colombo, N. Giancola, C. Moneta, G. Dionigi, L. Fugazzola, S. De Leo
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
2021 C. Colombo, S. De Leo, M. Di Stefano, M. Trevisan, C. Moneta, L. Vicentini, L. Fugazzola
Post-surgical ablative or adjuvant radioiodine therapy has no impact on outcome in 1–4 cm differentiated thyroid cancers without extrathyroidal extension
2021 S. De Leo, M. Trevisan, C. Colombo, G. Gazzano, S. Palazzo, L. Vicentini, L. Persani, L. Fugazzola
The informative experience of endocrine residents with COVID-19
2020 M. Di Stefano, S. Federici, L. Giovanelli, B. Nadiani, F. Nicoli, M. Trevisan